Soluble tissue factor as predictor of future events in patients with acute myocardial infarction

By Seljeflot I.   Hurlen M.   Hole T.   Arnesen H.  

Thrombosis Research, Vol. 111, Iss. 6, 2003-01 ,pp. : 369-372

Elsevier

Access to resources Recommend Favorite

Tissue Factor Pathway Inhibitor Endocytosis

By Schwartz A.L.   Broze G.J.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 7, 1997-10 ,pp. : 234-239

Elsevier

Access to resources Recommend Favorite

Factor VII, Tissue Factor Pathway Inhibitor, and Monocyte Tissue Factor in Diabetes Mellitus: Influence of Type of Diabetes, Obesity Index, and Age

By Vambergue A.   Rugeri L.   Gaveriaux V.   Devos P.   Martin A.   Fermon C.   Fontaine P.   Jude B.  

Thrombosis Research, Vol. 101, Iss. 5, 2001-03 ,pp. : 367-375

Elsevier

Access to resources Recommend Favorite

The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediated ex vivo platelet function in acute myocardial infarction

By Spiel Alexander   Mayr Florian   Ladani Nathalie   Wagner Patricia   Schaub Robert   Gilbert James   Jilma Bernd  

Platelets, Vol. 20, Iss. 5, 2009-08 ,pp. : 334-340

Informa Healthcare

Access to resources Recommend Favorite

Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the national registry of myocardial infarction 4

By Peterson E.D.   Pollack C.V.   Roe M.T.   for the National Registry of Myocardial Infarction NRMI 4 Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 15-15

Elsevier

Access to resources Recommend Favorite